FTSE 100 news / Companies and sectors / AstraZeneca / 11 October 2026
AstraZeneca (AZN): news on Sunday 11 October 2026
+7.0 strongly positive
Coverage was mainly about AstraZeneca's new AI tie-up for its biologics labs and a senior hire in solid tumour cell therapy. Both are modestly positive for its research pipeline.
What drove it
- AI biologics discovery partnership
- cell therapy hire
The 2 stories
- +8.5 AstraZeneca (LSE:AZN) Puts AI Into Biologics Labs With New Discovery Tie Up
New AI discovery partnership for biologics labs is a positive development. - +3.7 Levi Gray-Rupp Joins AstraZeneca as Global Product Lead, Solid Tumor Cell Therapy
Senior hire in cell therapy supports oncology build-out.
AstraZeneca: every day · Pharma and healthcare on 11 October 2026 · FTSE 100 overview for the day